New drug duo targets hard-to-treat lung cancer mutation
NCT ID NCT07164170
First seen Nov 01, 2025 · Last updated May 08, 2026 · Updated 22 times
Summary
This study tests a combination of two experimental drugs, ABSK043 and glecirasib, in people with advanced non-small cell lung cancer that has a specific mutation called KRAS G12C. The goal is to see if the combination is safe and shrinks tumors. About 86 adults will take part in this open-label phase 2 trial.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Beijing Cancer Hospital
Beijing, Beijing Municipality, China
Contact
Contact
-
Cancer Hospital Chinese Academy of Medical Sciences
Beijing, Beijing Municipality, China
-
Central Hospital Affiliated to Shangdong First Medical University
Jinan, Shangdong, China
Contact
Contact
-
Fujian Cancer Hospital
Fuzhou, Fujian, China
Contact
Contact
-
Guangxi Medical University Cancer Hospital & Guangxi Cancer Institude
Nanning, Guangxi, China
-
Harbin Medical University Cancer Hospital
Harbin, Heilongjiang, China
-
Henan Cancer Hospital
Zhengzhou, Henan, China
-
Hunan Cancer Hospitial
Changsha, Hunan, China
-
Shanghai Chest Hospital
Shanghai, Shanghai Municipality, China
Contact
Contact
-
Shanghai Pulmonary Hospital
Shanghai, Shanghai Municipality, China
Contact
Contact
-
The First Affiliated Hospital of Anhui Medical University
Hefei, Anhui, China
-
The First Affiliated Hospital of Sun Yat-sen University
Guangzhou, Guangdong, China
-
The First Affiliated Hospital of Xi'an Jiaotong University
Xi’an, Shanxi, China
Contact
Contact
-
The First Hospital of China Medical University
Shenyang, Liaoning, China
-
Tongji Hospital Tongji Medical College of Hust
Wuhan, Hubei, China
-
West China Hospital Sichuan University
Chengdu, Sichuan, China
-
Zhongda Hospital Southeast University
Nanjing, Jiangsu, China
Conditions
Explore the condition pages connected to this study.